Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma
in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst
diameter, the associated pain and side effect of the oral desogestrel.